Your browser doesn't support javascript.
loading
Risk Factors for Higher-than-Expected Residual Rivaroxaban Plasma Concentrations in Real-Life Patients.
Kaserer, Alexander; Schedler, Andreas; Jetter, Alexander; Seifert, Burkhardt; Spahn, Donat R; Stein, Philipp; Studt, Jan-Dirk.
Afiliação
  • Kaserer A; Institute of Anaesthesiology, University and University Hospital Zurich, Zurich, Switzerland.
  • Schedler A; Institute of Anaesthesiology, University and University Hospital Zurich, Zurich, Switzerland.
  • Jetter A; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.
  • Seifert B; Department of Biostatistics and Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Spahn DR; Institute of Anaesthesiology, University and University Hospital Zurich, Zurich, Switzerland.
  • Stein P; Institute of Anaesthesiology, University and University Hospital Zurich, Zurich, Switzerland.
  • Studt JD; Division of Haematology, University and University Hospital Zurich, Zurich, Switzerland.
Thromb Haemost ; 118(5): 808-817, 2018 05.
Article em En | MEDLINE | ID: mdl-29614520
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Inibidores do Fator Xa / Rivaroxabana Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Inibidores do Fator Xa / Rivaroxabana Idioma: En Ano de publicação: 2018 Tipo de documento: Article